Evidence map›Paper›PMID 35002536›Full record

ArticleMediators of inflammation2021

CircN4bp1 Facilitates Sepsis-Induced Acute Respiratory Distress Syndrome through Mediating Macrophage Polarization via the miR-138-5p/EZH2 Axis.

Dongyang Zhao, Chunxue Wang, Xiandong Liu, Na Liu, Shougang Zhuang, Qianqian Zhang, Xiaowei Bao, Shumin Xu, Xiaohui Zhou, Qinshu Meng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. The role of mFrontiers in immunology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Functional roles of circular RNAs in lung injury.Frontiers in pharmacology · 2024
    Review
  15. Role and regulators of NFrontiers in pharmacology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Dongyang Zhao *Department of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Chunxue Wang *Department of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Xiandong LiuDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Na LiuDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Shougang ZhuangDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Qianqian ZhangDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Xiaowei BaoDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Shumin XuDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Xiaohui ZhouResearch Center for Translational Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, China.
Qinshu MengResearch Center for Translational Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, China.
Shao LiDepartment of VIP Clinic, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-0411-6986
Lunxian TangDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.ORCID https://orcid.org/0000-0002-5726-9380
Shanghai East Hospital · CNBrown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported the differential circRNA expression patterns of the pulmonary macrophages in sepsis-induced acute respiratory distress syndrome (ARDS) mice model by microarray analysis. However, their function and hidden molecular mechanism in regulation of macrophage activation and inflammation remain poorly understood. In this study, we found that circN4bp1was overexpressed in PBMC and monocytes, and its expression levels were correlated with a poor prognosis in sepsis induced ARDS patients induced by sepsis. Knockdown of circN4bp1 inhibited the lung injury and improved the long-time survival through blunting the M1 macrophage activation in cecal ligation and puncture- (CLP-) induced ARDS mice. Moreover, bioinformatics analysis predicated a circN4bp1/miR-138-5p ceRNA network, which was confirmed by luciferase reporter assay and RNA binding protein immunoprecipitation (RIP). CircN4bp1 affected macrophage differentiation by binding to miR-138-5p, thus regulating the expression of EZH2 in vivo and ex vivo. Lastly, the m6A level of circN4bp1was found to be elevated in ARDS mice; inhibition of m6A methyltransferase METTL3 blocked this response in vitro. Therefore, circN4bp1 can function as a miR-138-5p sponge for the modulation of macrophage polarization through regulation the expression of EZH2 and may serve as a potential target and/or prognostic marker for ARDS patients following sepsis.

Indexed as

MicroRNAsRespiratory Distress SyndromeRNA, CircularSepsisAnimalsEnhancer of Zeste Homolog 2 ProteinHumansLeukocytes, MononuclearMacrophage ActivationMacrophagesMethyltransferasesMiceNuclear ProteinsRNA-Binding ProteinsEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanMethyltransferasesMETTL3 protein, humanMicroRNAsMIRN138 microRNA, humanN4BP1 protein, humanNuclear ProteinsRNA-Binding ProteinsRNA, Circular

Identifiers

PMID35002536
PMCPMC8739551
OpenAlexW4226262924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.